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Systemic stress responseTick-borne encephalitis virus (TBEV) induces acute central nervous system (CNS) disease in humans. In this
study, we investigate the pathogenetic mechanisms that correlate with fatal infection with TBEV in a mouse
model. Following subcutaneous infection with high challenge doses (N107 PFU), mice started to die early
(8 days) and mortality rates reached N80%. These doses induced acute and widespread infection of the CNS.
On the other hand, following subcutaneous infection with low challenge doses (102–106 PFU), mice started to
die late (11 days) and approximately one half of the mice survived but exhibited degrees of encephalitis
similar to dying mice. However, low dose dying mice exhibited severe systemic stress response, and
increased levels of TNF-α compared with recovering mice. We therefore conclude that in addition to the
development of CNS disease, systemic inﬂammatory and stress responses contribute to induce a fatal
infection following subcutaneous infection of mice with TBEV.
© 2009 Elsevier Inc. All rights reserved.Introduction
Tick-borne encephalitis virus (TBEV), which belongs to the genus
Flavivirus in the family Flaviviridae, is a causative agent of acute central
nervous system (CNS) disease in humans (Dumpis, Crook, and Oksi,
1999; Lindquist andVapalahti, 2008). TBEV is prevalent over awide area
of Europe and Asia, and is geographically and genetically divided into
three subtypes comprising the European, Siberian and far-eastern sub-
types (Ecker et al., 1999; Hayasaka et al., 2001b). TBEV infects humans
through the bite of an infected tick and the endemic areas of Europe andsaka@nagasaki-u.ac.jp
nih.go.jp (Y. Fujii),
Sata),
. Takashima),
of Tropical Medicine, Nagasaki
8195 819 7830.
ll rights reserved.Asia correspond to the geographical distribution of Ixodes tick species
(Burke and Monath, 2001; Dumpis, Crook, and Oksi, 1999).
In human cases, Tick-borne encephalitis (TBE) characteristically
takes a biphasic course involving an acute febrile illness, a period of
apparent recovery, followed by a neurological syndrome (Holzmann,
2003; Lindquist and Vapalahti, 2008). The neurological symptoms
include headache, meningitis, meningoencephalitis and meningoen-
cephalomyelitis, the latter being observed in the most severe cases.
When death follows, it is usually within 5 to 7 days of the onset of
neurological signs (Dumpis, Crook, and Oksi, 1999). Such clinical
features are not unique toTBE, thus, laboratory diagnosis is required to
distinguish it from other neurological disorders (Charrel et al., 2004;
Holzmann, 2003).
The pathological ﬁndings in the brains of human cases are
nonspeciﬁc and lesions are located in the brain stem, cerebrum,
cerebellar cortex, pons, cerebellum, thalamus and motor neurons
(Dumpis, Crook, and Oksi, 1999; Gelpi et al., 2005; Gelpi et al., 2006).
TBEV antigens are immunohistochemically detectable in lesions of the
large neurons (Gelpi et al., 2005), suggesting that TBEV can infect
neurons widespread throughout the brain. Hence, TBE may present
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due to the different sites at which neuronal dysfunctions occur in the
CNS.
The laboratory mouse model is the most commonly employed
systemwith which to study the CNS pathology of TBEV in vivo because
mice develop neurological symptoms similar to those observed in
humans and develop relatively comparable neurological dysfunction
(Chiba et al., 1999; Pogodina and Savinov, 1964; Sokol, Libikova, and
Zemla, 1959; Vince and Grcevic, 1969). Thus, death has been used as
an index of pathogenesis and lethal dose has often been determined.
Mouse infection, following either the subcutaneous or intradermal
route, is considered to be a reproducible model of natural human
infections that may result from the bite of an infected tick.
The pathogenetic process following experimental infection with
TBEV is fundamentally similar to that of other encephalitic ﬂaviviruses
including Japanese encephalitis virus (JEV), West Nile virus (WNV)
and Murray Valley encephalitis virus (MVEV) (Albrecht, 1968; Burke
and Monath, 2001; Garcia-Tapia et al., 2007). From studies of
encephalitic infections by these viruses, it is believed that initial
virus replication occurs in dendritic cells (DCs) such as Langerhans
cells at the site of infection, and the infected DCs migrate to draining
lymph nodes. After viremia and replication in peripheral organs, virus
invades the CNS and these hosts develop CNS disease, although the
mechanism by which the blood-brain-barrier is crossed is not
completely understood (Byrne et al., 2001; Dumpis, Crook, and Oksi,
1999; Robertson et al., 2009; Samuel and Diamond, 2006).
The CNS pathology of TBEV involves two distinct features,
neuroinvasiveness and neurovirulence (Mandl, 2005; Monath,
1986). Direct intracerebral infection usually results in high mortality
rates and 50% lethal doses (LD50) are often below 1 PFU (Chiba et al.,
1999; Monath et al., 1980). Therefore, it is generally believed that after
viruses enter the CNS, the host develops lethal encephalitis. Thus,
mortality rates following direct intracerebral infection represent
neurovirulence, whereas mortality following peripheral infection
represents neuroinvasiveness (Mandl, 2005).
Interestingly, it is known that mice do not exhibit a normal dose
response curve of mortality following peripheral infection with some
strains of encephalitic ﬂavivirus. This phenomenonwas ﬁrst reported in
the 1940s (Lennette, 1944). Although the reason for these apparent
discrepancies is not fully understood, it is generally considered that dose
independence is attributable to the outcome of viral infections in
peripheral tissues before CNS entry. However, this hypothesis is
controversial, because some mice recovered from illness with neuro-
pathological sequelae following peripheral infection (Chiba et al., 1999;
Hayasaka et al., 2004; Hayasaka et al., 2001b; Hayasaka et al., 1999).
Thus, it is considered likely that virus neuroinvasion following
peripheral infection does not simply determine whether or not the
mice will die; rather, mortality is determined after the development of
CNS disease. Therefore, in order to understand the basis of dose
independent mortality, it is necessary to examine the development of
CNS pathology that relates to disease severity and mortality.
CNS pathology is the consequence of viral infection of the
corresponding cells and the resulting inﬂammatory responses in the
CNS. Direct viral infection of neurons is considered to be the major
cause of neurological disease, because viral infections cause apoptosis
or degeneration of neurons in vivo and in vitro (Couderc et al., 2002;
Liao et al., 1997; Prikhod'ko et al., 2001; Shrestha, Gottlieb, and
Diamond, 2003). In addition, recent studies have demonstrated that
inﬂammatory responses in the CNS have immunopathological effects
(Iwasaki et al., 1986; King et al., 2007). For the mechanism of CNS
pathology following TBEV infection, Vince and Grcevic (1969) showed
that peritoneal infections of mice with TBEV, exhibit distinct patterns
of CNS pathology involving meningovascular, angioencephalotoxic
and degenerative patterns. However, it is not known how, or if,
these pathological features correlate with disease development and
mortality.Our previous studies in mice reported that the far-eastern subtype
of TBEV Oshima strain, which was isolated in Japan (Takashima et al.,
1997), has a pathogenetic potential common among TBE viruses
(Chiba et al., 1999; Hayasaka et al., 2001b; Hayasaka et al., 1999).
However, the detailed mechanisms of CNS pathology and mortality
were not fully elucidated. Thus, the purpose of this study was to
investigate these mechanisms by addressing the following questions
(i) do morbidity and virus neuroinvasion directly correlate with
mortality, (ii) do surviving mice develop the CNS pathology and (iii)
does mortality result from a single or multiple mechanisms, following
subcutaneous infection with TBEV?
Results
Dose independent mortality in inbred mice after subcutaneous infection
with the Oshima strain of TBEV
Previous reports showed that the TBEV Oshima strain elicited dose
independent mortality in outbred ICR mice following peritoneal
infection (Chiba et al., 1999; Hayasaka et al., 2001a). Thus, we used
inbred B6 mice in this study to eliminate the inﬂuence of the genetic
background in outbred mice. Following subcutaneous infection of
groups of mice with sequentially increasing doses, mice did not
exhibit a normal dose dependent curve of mortality (Fig. 1A). Two
distinct mortality rate responses were observed one in which more
than 80% of themice died following a high virus challenge dose (107 or
107.8 PFU) and the other inwhich 40 to 60% of the mice died following
a lower virus challenge dose (from 102 to 106 PFU) (Fig. 1A). It is
important to emphasize that in this lower challenge dose category
there was no obvious difference in mortality rates at any of the
challenge doses, even though the doses differed by several orders of
magnitude.
Following high dose infections, mice started to die at 8 days
post infection (pi) (Fig. 1B) and mean survival times (MSTs) were
12.8±3.1 days without signiﬁcant differences between 107 and
107.8 PFU as the challenge dose. On the other hand, following the
lower challenge dose infections, mice did not start to die until 11 days
pi (Fig. 1B) and MSTs were 15.8±2.9 days with no signiﬁcant
difference between the challenge doses (102 to 106 PFU). However,
there was a signiﬁcant difference in MSTs between high and low
challenge doses (Pb0.01).
Morbidity in mice
All TBEV-infected mice remained asymptomatic for several days
following infection, and then exhibited generalized clinical signs
involving weight loss, slowness in movement, ataxia, piloerection and
anorexia. Elevated body temperature was not observed, but hypother-
mia was induced (data not shown). Some mice exhibited neurological
signs of paralysis involving rigidity and ﬂaccid paralysis from 7 to
11 days pi.
In particular, body weight loss was the ﬁrst clinical observation.
Thus, we estimated the onset of disease by whether or not the weight
of each mouse decreased compared with control uninfected mice. As
shown in the survival curves (Fig. 1B), high dose infections elicited
early onset of weight loss, whereas low dose infections induced
delayed onset (Fig. 1C). The mean times to the onset of weight loss
were 6.4±0.49 and 8.1±0.96 days pi following high or low dose
infections, respectively.
Virus neuroinvasion alone does not induce fatal infection
It is important to note, that morbidity rates did not correlate
directly with mortality rates since all low challenge doses (N102 PFU)
induced morbidity in 100% of mice regardless of whether or not they
survived infection (Fig. 1D). All brains infected with N102 PFU of TBEV
Fig. 1. Mortality and morbidity following subcutaneous infection with TBEV Oshima strain in B6 mice. Ten mice in each group were subcutaneously infected with increasing
concentrations of virus ranging from 10−1 to 107.8 PFU. Mortality rates (A) and survival curves (B) were recorded for 21 days after high (107 and 107.8 PFU) and low (102 to 106 PFU)
dose infections and none of the mice died after 21 days. Mice were monitored daily for signs of disease and the average ratios of weight change of living mice at the time points
comparedwith those of day 0 were recorded following high (107 and 107.8 PFU) and low (102 to 106 PFU) dose infection (C). Error bars represent the standard deviations. Morbidity of
micewas estimated by degree of weight loss after 21 days (D). The averages of daily weight change of surviving or dyingmiceweremonitored after low dose infections (E). Error bars
represent the standard deviations. Individuals of surviving or dying mice were plotted in the degree of weight ratio at 13 days post infection (F).
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weight loss, but viral loads did not show a dose dependent correlation
(data not shown).
Moreover, 20% of the surviving mice had presented with apparent
neurological signs, including hind-limb hemiparesis following reco-
very, whereas 80% of the dead mice exhibited paralysis before death.
Thus, since CNS disease was observed in both surviving and non-Fig. 2. Virus replication in peripheral organs and CNS following high (107 PFU) or low (103 PF
blood (A), lung (B), thymus (C), spleen (D), brain (E) and spinal cord (F). Error bars indicasurviving mice, neuroinvasiveness is not a sufﬁcient condition to
ensure a fatal consequence.
Discrimination of dying and recovering mice
Although surviving mice also exhibited virus neuroinvasion and
clinical disease symptoms, it was uncertain if these mice actuallyU) dose infections. Titers per g of tissue represent the average from three to ﬁve mice in
te the standard deviations.
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correlation with mortality, we needed to be able to discriminate
between dying and recovering mice during the observation period. To
achieve this we followed the progression of weight change of mice
that died or survived following low challenge doses. Mice that died
exhibited continuous weight loss until death, whereas survivorsFig. 3. Viral loads in distinct regions of the CNS and their histopathological features at early p
and spinal cord of ﬁve mice infected with 107 PFU (A) or 103 PFU (B) infections at 7 days pi. T
analysis of variance. Asterisks show the pairs that exhibit signiﬁcant differences by Student
brain cortex (C to E), cerebellum (F to H), brainstem (I to K) and spinal cord (L to N) in mice
8 days pi. TBEV antigens were detected using E protein speciﬁc TBEV antibody (insets). Eacregained weight from 13 to 15 days pi (Fig. 1E), but the day of onset of
weight loss was not signiﬁcantly different. In fact, dead mice and
survivors were clearly distinguished by whether or not mice showed
less than 0.75 of the weight ratio, 13 days pi (Fig. 1F). From these
observations, we could discriminate dying and recovering mice by the
degree of weight change during the later period of infection.eriods following infection. Viral loads in brain cortex, thalamus, cerebellum, brainstem
he error bars indicate the standard errors. P value in each graph was determined by the
T test in the graph that indicates Pb0.05 by the analysis of variance. Histopathology of
infected with 107 PFU (C, F, I and L), 103 PFU (D, G, J and M) and mock (E, H, K and N) at
h experiment represents three mice.
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A major cause of disease development is considered to be direct
viral infection and replication in the CNS. Therefore, we followed the
development of viral load in mice following peripheral challenge with
high (107 PFU) or low (103 PFU) infectious doses to look for evidence
of a correlation between viral replication, disease development and
time of death.
Following a high challenge dose infectious virus was detected from
0 to 3 days pi in blood, lung, thymus and spleen, and peaked 1 to
2 days later (Figs. 2A to D). On the other hand, following a low
challenge dose, initial virus replication and/or the peak levels were
delayed 1 to 2 days compared with the high challenge dose, although
overall viral loads were not signiﬁcantly different (Figs. 2A to D).
Either of the challenge doses was reduced to below detection limits by
approximately 10 days pi. Therefore, virus replication in peripheral
organs did not appear to correlate with the progression of disease to
death.
In CNS, following high challenge doses, infectious virus was
detectable in the brain and spinal cord at 1 day pi, indicating that
virus replication in CNS occurred almost simultaneously with replica-
tion in the peripheral organs (Figs. 2E and F). On the other hand,
following the lowchallenge dose, infectious viruswas detected ondays
3 and 7 pi in brain and spinal cord, respectively (Figs. 2E and F). Thus,Fig. 4. Inﬂammatory responses in brains at 8 days pi after infection with mock, 107 PFU or 10
in brains of ﬁvemice per group. Inﬂammatory cytokines in brains of ﬁvemice in each group a
IL-2 (E), IL-10 (F) and TNF-α (G) are shownas the copynumbers compared to 107 copies of GA
by the analysis of variance. Asterisks show the pairs that exhibit signiﬁcant differences by Stthese observations probably explain the different lengths of time of
illness onset between high and low challenge doses (Fig. 1C).
The peaks of viral loads in CNS were 7 days pi following high dose
infections (Figs. 2E and F), indicating thatmice started to die at around
the peak of viral load in the CNS. On the other hand, the peaks were
9 days pi following low dose infections (Figs. 2E and F). Subsequently,
as the time post-infection increased, CNS viral loads gradually
decreased (Figs. 2E and F), indicating that mice died during clearance
of virus from the CNS. These data suggest that themechanism of death
is different in high and low challenge doses.
It is important to note that infectious virus was detected in the CNS
of all mice infected with either high or low challenge doses even at
21 days pi by which time surviving mice had completely recovered
fromweight loss (Figs. 2E and F). Thus, virus neuroinvasion still occurs
in all mice that survive infection.
CNS pathology in mice at early days post infection
Since high but not low challenge dose caused early death (Fig. 1B),
we compared CNS pathology early after infection with either high or
low challenge doses. High challenge dose (107 PFU) infections resulted
in high viral loads with more than 106 PFU per g of tissue in every
region of the CNS tested without signiﬁcant differences (Fig. 3A). In
contrast, a low challenge dose (103 PFU) resulted in signiﬁcantly lower3 PFU per mouse. Number of inﬁltrating leukocytes (A), CD8+ T cells (B) and B cells (C)
t 8 days pi were quantiﬁed by real-time PCR. The expression levels of mRNA of IFN-γ (D),
PDHmRNA. Error bars indicate the standard errors. P value in each graphwas determined
udent T test in the graph that indicates Pb0.05 by the analysis of variance.
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comparedwith that of the brain cortex; inwhich viral loadwas similar
to the high challenge dose (Fig. 3B).
Corresponding to the viral loads, histopathological examination
showed that acute necrotic neurons with TBEV antigens and inﬂam-Fig. 5. Viral loads and the histopathological features in CNS during the late period of infection
weight loss was more or less than 0.75. Viral loads in brain cortex, thalamus, cerebellum, bra
error bars indicate the standard errors. P value in each graphwas determined by the analysis
in the graph that indicates Pb0.05 by the analysis of variance. Histopathology of brain cortex
(C, F, I and L), and recoveringmice (D, G, J andM) andmock-infectedmice (E, H, K and N) at 1
TBEV-speciﬁc E protein antibody (insets). Each experiment represents three mice.matory reactions were observed widely throughout the CNS involving
brain cortex (Fig. 3C), thalamus (data not shown), cerebellum
(Fig. 3F), brainstem (Fig. 3I) and spinal cord (Fig. 3L) following the
high challenge dose. On the other hand, following the low challenge
dose, some necrotic neurons displayed TBEV antigens and slightafter 103 PFU dose. Dying and recoveringmicewere distinguishedwhether the degree of
instem and spinal cord of ﬁve mice either dying (A) or recovering (B), at 13 days pi. The
of variance. Asterisks show the pairs that exhibit signiﬁcant differences by Student T test
(C to E), cerebellum (F to H), brainstem (I to K), and spinal cord (L to N) in dying mice
5 days pi following challengewith 103 PFU permouse. TBEV antigenswere detected with
145D. Hayasaka et al. / Virology 390 (2009) 139–150cufﬁng was also observed in the brain cortex (Fig. 3D), thalamus (data
not shown), cerebellum (Fig. 3G), brainstem (Fig. 3J) and spinal cord
(Fig. 3M), but the degree of neuronal degeneration was lower in
cerebellum, brainstem and spinal cord when compared with that
following high challenge doses (Figs. 3G, J and M). In particular,
Purkinje cells were still intact following low dose infection (Fig. 3G),
but they showed severe degeneration following high dose infection
(Fig. 3F). Mock-infectedmice showed no neuronal degeneration, TBEV
antigens or inﬂammatory reactions (Figs. 3E, H, K and N).
The inﬂammatory responses were assessed by measuring cell
inﬁltration and levels of inﬂammatory cytokines present in brains at
8 days pi. Inﬁltrating leukocyte levels were signiﬁcantly increased in
both high and low challenge dose groups of mice compared with
mock-infections (Fig. 4A). CD8+ T cells (Fig. 4B), CD4+ T cells,
neutrophils and natural killer cell levels (data not shown) were also
signiﬁcantly increased, whereas B cell (Fig. 4C) andmacrophage levels
(data not shown) were decreased. However, there was no correlation
between these increases or decreases with virus challenge dose.
Inﬂammatory cytokine levels of IFN-γ, IL-2, IL-10 and TNF-α also
increased but again therewas no correlationwith virus challenge dose
(Figs. 4D to G). Whilst individual levels of cytokines tended to be
higher in high virus challenge dose mice, the differences were not
signiﬁcant (Figs. 4D to G).Fig. 6. Inﬂammatory response in brains of dying and recoveringmice at late time of infection
CD8+ T cells (B) and B cells (C) in brains of ﬁve mice per group at 13 days pi. Inﬂammatory c
PCR. The expression levels of mRNA of IFN-γ (D), IL-2 (E), IL-5 (F), IL-10 (G) and TNF-α (H
indicate the standard errors. P value in each graph was determined by the analysis of varian
graph that indicates Pb0.05 by the analysis of variance.Thus, the results suggest that early death following high virus
challenge dose, primarily results from acute neurological dysfunction
throughout the CNS directly due to viral cytopathic effects rather than
generalized immunopathological effects.
CNS pathology in mice at late days post infection following low
challenge dose
We subsequently investigated the CNS pathology in low challenge
dose mice (103 PFU) as above. In mice dying at 13 days pi, the viral
load in brains was 105.7±0.20 PFU per g of tissue. This titer was lower
than the peak levels (106.3±0.11 PFU per g of tissue), although the
difference was not signiﬁcant. In recovering mice at 13 days pi, the
viral load in brains was 105.4±0.21 PFU per g of tissue without
signiﬁcant difference from that of dying mice. However, interestingly,
the viral load in the cerebellumwas signiﬁcantly increased (106.5±0.24
and 106.5±0.24 PFU per g of tissue) compared with that observed
earlier, i.e. at 7 days pi (104.0±0.44 PFU per g of tissue) in both dying
and recovering mice (Figs. 5A and B). In other words, the viral load in
the cerebellum was signiﬁcantly higher than that in the brain cortex,
thalamus, brainstem and spinal cord (Figs. 5A and B). These
observations indicate that viral infection alone is not a critical
determinant of late death, unlike that of early death.following either mock or 103 PFU challenge doses. Number of inﬁltrating leukocytes (A),
ytokines in brains of ﬁve mice in each group at 13 days pi were quantiﬁed by real-time
) are shown as the copy numbers compared to 107 copies of GAPDH mRNA. Error bars
ce. Asterisks show the pairs that exhibit signiﬁcant differences by Student T test in the
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examination showed inﬂammatory reactions with focal proliferation
of microglial rod cells in the brain cortex (Figs. 5C and D), thalamus
(data not shown), cerebellum (Figs. 5F and G), brainstem (Figs. 5I
and J) and spinal cord (Figs. 5L and M). Severe inﬂammatory inﬁl-
trationwithmononuclearcells and rod shapedmicrogliawere observed
in the cerebellum, meninges and cortex with degenerate Purkinje cells
(Figs. 5F and G). TBEV antigens were not detected or only weakly
detected in cell debris (Figs. 5FandG). These pathological featureswere
not observed in mock-infected mice (Figs. 5E, H, K and N).
The numbers of inﬁltrating leukocytes were increased in both
dying and surviving/recovering mice compared with mock-infected
mice (Fig. 6A). Levels of CD8+ Tcells (Fig. 6B), B cells (Fig. 6C), CD4+ T
cells, neutrophils, natural killer cells and macrophages (data not
shown) were also increased. In both dying and surviving/recovering
mice, the levels of inﬂammatory cytokines involving IFN-γ, IL-2, IL-5,
IL-10 and TNF-α in the brain were increased compared with mock-
infected mice (Figs. 6D to G). Although the levels of TNF-α increased,
they were lower in recovering mice than in dying mice (Fig. 6H).
Taken together, these observations suggest that following low
challenge dose, mice developed encephalitis but showed features ofFig. 7. Systemic stress response and expression of inﬂammatory cytokines in mice following a
(B), and the percentage expression CD4+CD8+ double positive cells (C) in dying and recov
TNF-α (H), in the serum of dying and recoveringmice. Cytokines present in ﬁvemice per gro
(E) and TNF-α (I) of mice were also measured after 107 PFU or 103 PFU challenges at 8 days
the analysis of variance. Asterisks show the pairs that exhibit signiﬁcant differences by Studvirus clearance from the CNS. Moreover, increased viral infections in
the cerebellum with degenerating Purkinje cells were characteristi-
cally observed. However, for death to occur, whilst the development of
CNS pathology is essential, it does not determine fatality following
subcutaneous infection of mice with TBEV.
Systemic stress responses in dying mice
Since CNS pathology was detected in both surviving and dying
mice, we have concluded that neurological dysfunction alone does not
determine mortality. Therefore, we compared the peripheral pathol-
ogy and systemic responses of dying and surviving mice.
Although the histopathological features in peripheral organs were
not signiﬁcantly different (data not shown), severe atrophy of the
thymus and spleenwere seen only in dyingmice. Indeed, the numbers
of thymocytes and splenocytes were dramatically decreased in dying
mice compared with mock-infected mice and surviving mice (Figs. 7A
and B). Signiﬁcant reduction of CD4+ and CD8+ double positive cells
were the main cause of thymus atrophy (Fig. 7C). On the other hand,
overall phenotypes of splenocytes appear to be decreased (data not
shown). Viral loads were below detection limits in both thymus andchallenge dose of 103 PFU at 13 days pi. The number of thymocytes (A) and splenocytes
ering mice are represented. The level of corticosterone (D), IFN-γ (F), RANTES (G), and
upwere measured by enzyme-linked immunosorbent assay. The levels of corticosterone
pi. The error bars indicate the standard errors. P value in each graph was determined by
ent T test in the graph that indicates Pb0.05 by the analysis of variance.
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tion of thymocytes and splenocytes is unlikely to be the main cause of
their atrophy.
Thymic depletion and bodyweight loss are themain features of the
systemic stress response (Dunn et al., 1989; Savino, 2006). These data
therefore raise the possibility that severe systemic stress responses
were elicited in dying mice. Corticosterone is a major glucocorticoid
hormone, the levels of which are elevated under a stress response
condition (Dunn et al., 1989; Savino, 2006). Measurement of the levels
of corticosterone revealed that they were signiﬁcantly increased in
dying mice compared with mock-infected mice and surviving mice
(Fig. 7D), indicating that dying mice exhibited a severe stress
response.
However, decreased numbers of thymocytes and splenocytes (data
not shown) and increased levels of corticosterone (Fig. 7E) were
observed in mice early after infectionwith high (107 PFU) but not low
(103 PFU) virus challenge doses. Therefore, severe systemic stress
response appears to be a common factor in the lethal process of both
early and late death.
Increased levels of TNF-α in dying mice exhibiting late death
We subsequently investigated the levels of inﬂammatory cytokines
in the sera of infected mice at 13 days pi. The levels of IFN-γ, RANTES
and TNF-α were increased in both dying and recovering mice
compared with mock-infected mice (Figs. 7F to H), although the
levels of other inﬂammatory cytokines involving IL-1β, IL-2, IL-4, IL-6,
IL-10, IL-12 and MIP-1α did not signiﬁcantly differ among dying,
recovering and control mice (data not shown).
Although the increased levels of IFN-γ and RANTES were similar in
dying and surviving mice, TNF-α levels were signiﬁcantly increased in
mice that eventually died (Fig. 7H). This was not the case in mice early
after infection with either high or low virus challenge doses (Fig. 7I).
Therefore, the increased level of TNF-α appeared to be a speciﬁc
response of late death.
Discussion
It is believed that CNS pathology is a major cause of disease
development and thusmortality is determined by the relative severity
of CNS pathology. However, in this study of subcutaneous infections
with TBEV, we have shown that fatality is determined by a complex
mechanism that includes severity of CNS pathology and systemic
responses that involve stress response and increased levels of TNF-α.
To investigate the pathogenesis of fatal infection in detail, we
distinguished dying and recovering/surviving mice by their degree of
weight loss. This novel approach proved to be both simple and
effective. Appetite depression probably caused the early weight loss
due to decreased food and water intake (data not shown). However, it
is unlikely that the undernourishment was the simple cause of death,
because our preliminary data showed that subcutaneous infusion
using glucose solution to compensate for weight loss did not prevent
TBEV-infected mice from dying.
For CNS pathology in encephalitic ﬂavivirus infections, virus
induced direct neuronal damage is considered to be a major cause
of neuronal dysfunction. High virus challenge doses rapidly induced
severe CNS pathology and mice almost certainly died due to the
resulting acute and widespread neuronal dysfunction. On the other
hand, low virus challenge doses did not cause such severe CNS
infections. Rather, brain cortex or cerebellum was preferably infected
either early or late following infection. In particular, speciﬁc
disappearance of Purkinje cells was observed at the late period post
infection when mice died. However, surviving/recovering mice also
showed the disappearance of Purkinje cells. Thus, CNS pathology
alone is unlikely to determine mortality following low challenge
doses.In addition to direct virus infection, recent studies indicate that
immunopathological effects on CD8+ T cells contribute to the severity
of CNS pathology (King et al., 2007). For example, Wang et al. (2003),
showed that CD8+ T cells have both protective and immunopatholo-
gical effects following subcutaneous infectionwith the Sarafend strain
of WNV in a laboratory mouse model. Experiments with MVEV also
indicated that CD8+ T cell function is pathogenic through the perforin
and Fas/FasL lysis pathways (Licon Luna et al., 2002). Moreover, the
recent work of Ruzek et al. (2009), clearly showed that CD8+ T cells
contribute to the survival times of mice infected with TBEV. Therefore,
in addition to the direct effect of viral infections, immunopathological
effects are also believed to contribute to the severity of CNS pathology.
However, in our results, it was not clear if CD8+ T cells correlated with
the stages leading to fatality, because the numbers of inﬁltrating CD8+
T cells were not signiﬁcantly different between surviving/recovering
and dying mice. Therefore, CD8+ T cells may function in other ways in
brain parenchyma to inﬂuence the protective/immunopathological
effects. Further studies are required to deﬁne the pathological effects
of CD8+ T cells in TBEV infections.
For the systemic response of dyingmice, we showed that the levels
of TNF-α were increased in brains and serum. TNF-α is a proinﬂam-
matory cytokine that is predominantly produced by activated
macrophages and T lymphocytes, but a wide range of cells and tissues
can also produce TNF-α (Bradley, 2008). Although TNF-α may
contribute beneﬁcially, inappropriate or excessive production can be
harmful (Bradley, 2008). A recent report showed that TNF-α has a
protective effect against WNV during the acute phase of infection
(Shrestha et al., 2008). However, it is not known if the increased levels
of TNF-α at the late phase of infection contribute beneﬁcially or
harmfully. Our preliminary data suggest that the injections of
neutralizing antibody to TNF-α after the onset of disease did not
show signiﬁcant effects on disease improvement or protection from
death. Thus, further study will be necessary to decide whether or not
increased levels of TNF-α contribute to the onset of late death.
We also showed that mice exhibited thymic and splenic atrophy
following TBEV infection. Similar pathological observations have been
observed in other infectious diseases and one major pathway is
related to the increased levels of glucocorticoid hormone such as
corticosterone in the blood (Savino, 2006). In fact, we observed that
the levels of corticosterone in the serum were increased in TBEV-
infected mice. Glucocorticoid is induced under stress conditions and
exerts immunomodulatory effects through activation of the hypotha-
lamic–pituitary–adrenal axis (Bailey et al., 2003; Ben-Nathan and
Feuerstein, 1990; Dunn et al., 1989; Savino, 2006), suggesting that
TBEV infections elicit stress responses inmice, in particular dyingmice
which show severe stress responses compared with recovering mice.
Repeated injection with corticosterone induced depression in mice
(Zhao et al., 2008). However, it is uncertain if the increased stress
response directly contributes to the mortality or if the response is
induced as a result of the lethal process.
Dose independent mortality induced by encephalitic ﬂaviviruses
has been recognized but has been an unresolved problem since the
1940s (King et al., 2007; Lennette, 1944). Here we have demon-
strated that dose independent mortality in which mortality rates
approximated to 50%, may occur following a wide range of relatively
low virus challenge doses. Other encephalitic ﬂavivirus strains
exhibiting dose independent mortality also show high (e.g. 100%)
and low (e.g. 20 to 60%) mortality rates following different
challenge doses (Licon Luna et al., 2002; Samuel and Diamond,
2006; Vince and Grcevic, 1969; Wang et al., 2006; Wang et al.,
2003). In addition, the observation of longer survival times in some
animals implies late death as reported herein. Thus, late death
following low virus challenge doses appears to be a key feature
of dose independent mortality within the encephalitic ﬂaviviruses.
However, the precise determinants of late death have not been
identiﬁed in this study.
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strains such as Sofjin (Far-eastern subtype), IR (Siberian subtype) and
Hochosterwitz (European-subtype) exhibited dose dependent mor-
tality following peripheral infection, whereas other strains such as
Oshima, KH, VL (Far-eastern subtypes) exhibited dose independent
mortality (Chiba et al., 1999; Hayasaka et al., 2001a; Hayasaka et al.,
2001b; Hayasaka et al., 1999). Of note, such dose dependent strains
elicited early death and 100% lethality rates even after low dose
infections. Sofjin strain exhibited extremely high replication in brains
compared with Oshima strain (Chiba et al., 1999), suggesting that
even low dose infections reached lethal levels of infection in the CNS
early after infection and neuroinvasiveness directly links to this
mortality. Thus, we propose that the ability of virus to replicate in the
CNS determines the pattern of mortality and the dose dependent or
independent mortality. However, further study is necessary to
examine whether or not different strains of TBEV present different
pathogenicities in the mouse model, because the patterns of
mortality are different between Sofjin and other strains of far-eastern
subtypes.
In human cases, TBE takes a biphasic course of acute febrile illness
and neurological syndrome, whereas mice did not exhibit elevated
body temperature. However, peripheral infections and viraemia were
observed in infected mice before neuronal infections. Thus, mice may
also present a biphasic course of illness, although it was difﬁcult to
observe the ﬁrst symptoms.
It is usually believed that human cases succumb to acute and
critical neuronal dysfunction following direct viral infection of the
neurons, suggesting that early death, as shown in this mouse study,
possibly relates to the mechanism of mortality in human cases. In
addition, our results indicate that systemic responses in late phases
potentially contribute to the severity and fatality of TBE in human
cases. Further elucidation of themechanism of late death in themouse
model is an important priority to enable the development of effective
treatment strategies for human TBE.
Materials and methods
Virus and cells
Stock virus of TBEV Oshima strain (Takashima et al., 1997) was
prepared from cell culture medium of baby hamster kidney (BHK)
cells that was infected with a previously prepared virus stock in
suckling mice brains (Hayasaka et al., 2001b). The BHK cells were
maintained in Eagle's Minimal Essential Medium (EMEM; Nissui
Pharmaceutical Co.) containing 8% fetal calf serum (FCS). All
experiments using live TBEV were performed in a biosafety level 3
laboratory of the Tokyo Metropolitan Institute for Neuroscience
according to the standard BSL3 guidelines.
Mice
Five-week old female C57BL/6j mice (Japan SLC Co.) were
subcutaneously inoculated with a range of 10−1–107.8 PFU of TBEV
diluted in EMEM containing 2% FCS. Mock-infected mice were
inoculated with EMEM from the supernatant medium of BHK cells.
Mice were weighed daily and observed for clinical disease
symptoms including behavioral symptoms and signs of paralysis.
Body temperatures of mice and the consumption of food and water
were also measured daily. Morbidity was determined by the relative
degree of weight loss compared with day 0. Thirteen days post
infection (pi), dying and recovering mice were distinguished by the
degree of weight ratio, namely mice exhibiting more than 25% or
less than 25% weight loss were recognized as dying or recovering
mice, respectively. The experimental protocols were approved by
the Animal Care and Use Committee of the Tokyo Metropolitan
Institute for Neuroscience.Virus titration in tissues
Every 2 days, three to ﬁve mice were sacriﬁced and blood, lung,
thymus, spleen, brain and spinal cord were collected following
perfusion with cold phosphate-buffered saline (PBS). Brains were
also collected and dissected to provide four separate fractions, i.e. the
brain cortex, thalamus, cerebellum and brainstem. Until they were
used, these organs were stored at −80 °C. Each organ was
homogenized in ten volumes of PBS containing 10% FCS and diluted
with EMEM with 2% FCS. Virus titers were determined by plaque
forming assays (Shirato et al., 2004) using BHK cells and were
expressed as PFU/g tissue.
Histopathological examination
Mice inoculated with TBEV were anesthetized and perfused with
10% phosphate-buffered formalin. Fixed tissues of thymus, lung, liver,
kidney, spleen, small intestine, brain, spinal cord, and maxilla
including nasal cavity were routinely embedded in parafﬁn, sectioned,
and stained with hematoxylin and eosin. Immunohistochemical
detection of the TBEV antigens was performed as described previously
(Nagata et al., 2007). Rabbit polyclonal antibody against E proteinwas
used to detect TBEV antigens (Yoshii et al., 2004).
Recovery of leukocytes from brain, thymus and spleens
Recovery of leukocytes was performed using previously described
methods (Hayasaka, Ennis, and Terajima, 2007; Shrestha and
Diamond, 2004). Brieﬂy, brain leukocytes were isolated from mice
infected with mock, 107 or 103 PFU of virus at 8 and 13 days pi. After
perfusion with cold PBS, brains were removed and placed on ice in
RPMI containing 5% FCS (Nissui Pharmaceutical Co.). Brains were
strained and homogenized gently with a 70 μm cell strainer (BD
Biosciences). After washing with RPMI, the cell suspension was
layered onto a 70% and 30% Percoll gradient (GE Healthcare Bio-
Sciences AB) and centrifuged at 800×g for 45 min at 23 °C. The
leukocytes were collected from between the 70% and 30% interface.
Thymocytes and splenocytes were also recovered from these mice.
Cells were strained with a 70 μm cell strainer (BD Biosciences) and
lysed with RBC lysis buffer (Sigma-Aldrich). After washing, cells were
resuspended in RPMI medium. Isolated cells were counted and kept
on ice until the staining procedure.
Flow cytometric analysis of cell-surface antigens
Brain leukocytes, thymocytes and splenocytes were washed and
blocked with Rat Anti-Mouse CD16/32 (Fc Receptor) (Beckman
Coulter) in FACS buffer (PBS containing 0.1% BSA and 0.1% sodium
azide). Cells were stained with a mixture of different ﬂuorescent-
labeled antibodies directed at surface phenotypic markers, CD45,
CD3ε, CD4, CD8α, CD19, NK1.1 (Ly-55), Ly-6G (GR-1) (Beckman
Coulter) and F4/80 (AbD Serotec) and then ﬁxed with 4% parafor-
maldehyde overnight. The stained cells were analyzed by Epics Altra
(Beckman Coulter). Leukocytes were recognized by characteristic size
(forward scatter, FSC), granularity (side scatter, SSC) and CD45
expression. CD8+ T cells and B cells were recognized by CD3 and
CD8 expression, and CD19 expression in CD45+ leukocytes, respec-
tively. Thymocytes and splenocytes were recognized by their
characteristic size. CD4+CD8+ double positive cells were recognized
by the expression of CD4+ and CD8+ in the thymocytes.
Quantitative estimation of the expression of inﬂammatory cytokines
in brains
Five mice in each groupwere infected with mock, 107 or 103 PFU of
virus and brains were collected after perfusion with cold PBS at 8 and
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RNAlater (Ambion). Total RNA was extracted using RNeasy Lipid
Tissue Mini Kit (Qiagen) according to the manufacturer's instruction.
The expression levels of cytokines were measured by real time-PCR as
demonstrated previously (Fujii et al., 2008). The copy numbers were
calculated as a ratio of the copy numbers of internal control
glyceraldehyde-3-phosphate dehydrogenate (GAPDH).
Estimations of hormones and cytokine levels in the serum
Serum samples were collected from ﬁve mice infected with mock,
107 or 103 PFU of virus at 8 and 13 days pi. The levels in the serumwere
measured using competitive enzyme immunoassay and sandwich
enzyme-linked immunosorbent assay kits for corticosterone (Assay-
Pro), IFN-γ, TNF-α, IL-1β, IL-2, IL-4, IL-6, IL-10, IL-12 (Endogen), MIP-
1α, RANTES (R&D Systems) according to the manufacture's
instructions.
Statistical analyses
The analysis of variance and Student T test were used for statistical
analysis to assess the signiﬁcant differences of the degree of weight
change, viral loads, the numbers of leukocytes, the expression levels of
cytokines in brains and serum. P valueb0.05 was considered
statistically signiﬁcant.
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